Within 2 years of diagnosis, the combination of OPN and alpha-fetoprotein (AFP) best predicted HCC development, suggesting that measuring OPN and AFP could identify high-risk groups independently of a liver disease [110]. This evidence concerns the gene AFP and liver disorder.